Farallon Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $149M | Sell |
|
|||||
|
2024
Q4 | $348M | Buy |
|
|||||
|
2024
Q3 | $322M | Buy |
|
|||||
|
2024
Q2 | $363M | Sell |
|
|||||
|
2024
Q1 | $318M | Buy |
|
|||||
|
2023
Q4 | $117M | Sell |
|
|||||
|
2023
Q3 | $167M | Buy |
|
|||||
|
2023
Q2 | $138M | Buy |
|
|||||
|
2023
Q1 | $126M | Sell |
|
|||||
|
2022
Q4 | $120M | Buy |
|
|||||
|
2022
Q3 | $83.5M | Sell |
|
|||||
|
2022
Q2 | $88.8M | Buy |
|
|||||
|
2022
Q1 | $77.5M | Buy |
|
|||||
|
2021
Q4 | $75.6M | Buy |
|
|||||
|
2021
Q3 | $15M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $22.4M | Sell |
|
|||||
|
2020
Q4 | $102M | Hold |
|
|||||
|
2020
Q3 | $84.3M | Buy |
|
|||||
|
2020
Q2 | $84.2M | Buy |
|
|||||
|
2020
Q1 | $34.2M | Buy |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $76M | Sell |
|
|||||
|
2019
Q1 | $77.5M | Buy |
|
|||||
|
2018
Q4 | $69.8M | Buy |
|
|||||
|
2018
Q3 | $31.5M | Buy |
|